ESAB Q4 sales rise 7% to $721 million; GAAP diluted EPS falls to $0.82
ESAB reported fourth quarter and full year 2025 results that match the preliminary figures it released on February 2, 2026, filed alongside its 10-K. Reported sales grew, but GAAP earnings per share from continuing operations declined from the prior year, while core adjusted EPS rose. The company reaffirmed its 2026 outlook, which it said is consistent with its February 2 guidance.
Key points
- Q4 2025 sales were $721 million, up 7% reported but down 2% in core organic sales; Q4 GAAP diluted EPS from continuing operations was $0.82, versus $1.18 a year earlier.
- Q4 core adjusted EPS was $1.35, versus $1.28 in Q4 2024; full year core adjusted EPS was $5.27, versus $5.06.
- Full year 2025 sales were $2,843 million, up 4% reported and flat in core organic sales; full year GAAP diluted EPS from continuing operations was $4.10, versus $4.68 in 2024.
- For full year 2026, ESAB expects core adjusted EBITDA of $575 to $595 million and core adjusted EPS of $5.70 to $5.90.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.